Kazia Therapeutics (KZIA) Amortizatization of Intangibles (2016 - 2018)
Kazia Therapeutics (KZIA) posted Amortizatization of Intangibles of $388953.7 for Q4 2018, down 36.67% on a QoQ basis from $614211.9 in Q4 2017, and down 36.67% year-over-year from $614211.9 in Q4 2017.
Kazia Therapeutics (KZIA) has 3 years of Amortizatization of Intangibles data on file, last reported at $388953.7 in Q4 2018.
- In Q4 2018, Amortizatization of Intangibles fell 36.67% year-over-year to $388953.7; the TTM figure through Dec 2018 stood at $388953.7 (down 36.67% YoY), while the FY2025 annual figure was $598164.6, down 51.44% from the prior year.
- Amortizatization of Intangibles retreated to $388953.7 in Q4 2018, from $614211.9 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $614211.9 in Q4 2017 and bottomed at $378292.9 in Q4 2016.
- A 3-year average of $460486.2 and a median of $388953.7 in 2018 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2017 — Amortizatization of Intangibles surged 62.36% — and 2018, when it plunged 36.67%.
- Year by year, Amortizatization of Intangibles stood at $378292.9 in 2016, then surged by 62.36% to $614211.9 in 2017, then plunged by 36.67% to $388953.7 in 2018.
- The last three Amortizatization of Intangibles figures came in at $388953.7 (Q4 2018), $614211.9 (Q4 2017), and $378292.9 (Q4 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Kazia Therapeutics | 1.55 Bn | 1.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 388,953.75 |
| Dec 31, 2018 | 388,953.75 |
| Dec 31, 2017 | 614,211.87 |
| Dec 31, 2017 | 614,211.87 |
| Dec 31, 2016 | 378,292.88 |
| Dec 31, 2016 | 378,292.88 |